Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Tiotropium pMDI vs Spiriva Respimat in Healthy Volunteers
NCT03155204Phase 1Completed
- Sponsor
- Solventum
- Start
- Apr 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of tiotropium in chronic obstructive pulmonary disease (COPD) (5 arms), sponsored by Solventum. Primary endpoint: Peak Plasma Concentration. Started Apr 2017; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03155204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03155204.